Investments
31Portfolio Exits
1
Want to inform investors similar to Able Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Able Partners News
Jan 25, 2023
Journey Clinical , a New York-based company focused on providing psychedelic therapies, raised $8.5M in Series A funding. The round, which brings Journey Clinical’s total funding to ~$12M, was led by Union Square Ventures with participation from AlleyCorp, Fifty Years, Able Partners, Gaingels, Palo Santo, PsyMed Ventures, Coalition Operators, Mystic Ventures, Colibri, Satori Capital, and other angel investors. The company intends to use the funds to continue to scale its offerings across the US. Co-founded by Jonathan Sabbagh (CEO) and Myriam Barthes (COO), Journey Clinical provides both licensed psychotherapists and patients with access to psychedelic therapies. Licensed psychotherapists receive everything they need to confidently deliver PAP within their own practice, while eligible patients gain access to its medical team for evaluation and care, and network of licensed mental health professionals. The company started with Ketamine-Assisted Psychotherapy (KAP) and will expand to other psychotherapeutic treatments in the future as they continue to be validated, researched, and approved for broad use by the FDA. Since the company opened the platform in February 2022, they have grown from 30 to ~700 KAP psychotherapists, and have treated over 1,000 patients across the country. FinSMEs
Able Partners Investments
31 Investments
Able Partners has made 31 investments. Their latest investment was in Spring Health as part of their Series D on April 4, 2023.
Able Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/14/2023 | Series D | Spring Health | $71M | No | 2 | |
1/25/2023 | Series A | Journey Clinical | $8.5M | Yes | Able Partners, AlleyCorp, Coalition Operators, Colibri Group, Fifty Years Fund, Gaingels, Mystic Ventures, Palo Santo, PsyMed Ventures, Satori Capital, Undisclosed Angel Investors, and Union Square Ventures | 3 |
9/27/2022 | Seed VC | Cartwheel Care | $3.9M | Yes | 1 | |
9/16/2022 | Seed VC | |||||
5/2/2022 | Seed VC |
Date | 4/14/2023 | 1/25/2023 | 9/27/2022 | 9/16/2022 | 5/2/2022 |
|---|---|---|---|---|---|
Round | Series D | Series A | Seed VC | Seed VC | Seed VC |
Company | Spring Health | Journey Clinical | Cartwheel Care | ||
Amount | $71M | $8.5M | $3.9M | ||
New? | No | Yes | Yes | ||
Co-Investors | Able Partners, AlleyCorp, Coalition Operators, Colibri Group, Fifty Years Fund, Gaingels, Mystic Ventures, Palo Santo, PsyMed Ventures, Satori Capital, Undisclosed Angel Investors, and Union Square Ventures | ||||
Sources | 2 | 3 | 1 |
Able Partners Portfolio Exits
1 Portfolio Exit
Able Partners has 1 portfolio exit. Their latest portfolio exit was Compass Pathways on September 18, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/18/2020 | IPO | Public | 2 |
Date | 9/18/2020 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.